Placebo and active control dose response study of rivoglitazone in type 2 diabetics
Showing 26 - 50 of >10,000
Type 2 Diabetes Trial (HRS9531 injection, HRS9531 injection Placebo)
Not yet recruiting
- Type 2 Diabetes
- HRS9531 injection
- HRS9531 injection Placebo
- (no location specified)
Jul 21, 2023
Alveolar Bone Changes in Diabetes (ABCD) Study
Completed
- Diabetes Mellitus
- Well-controlled diabetic (WC)
- Poorly controlled diabetics (PC)
-
Minneapolis, Minnesota
- +2 more
Mar 1, 2022
Diabetes Trial (Lance CLEAR dental implant)
Not yet recruiting
- Diabetes
- Lance CLEAR dental implant
- (no location specified)
Aug 4, 2023
Diabetes, Type 2 Trial in Cruz-Quebrada (HIIT)
Not yet recruiting
- Diabetes Mellitus, Type 2
- HIIT
-
Cruz-Quebrada, Oeiras, PortugalFaculdade de Motricidade Humana
Nov 15, 2023
Diabetes, Pre-diabetes Trial in Doha (Checking diabetes development in follow up at 3 month)
Recruiting
- Diabetes
- Pre-diabetes
- Checking diabetes development in follow up at 3 month
-
Doha, DA, QatarHamad medical corporation
Aug 15, 2022
Retinopathy, Diabetic Trial in Coimbra (health educational sessions in diabetic patients type 2.)
Not yet recruiting
- Retinopathy, Diabetic
- health educational sessions in diabetic patients type 2.
-
Coimbra, PortugalAIBILI-CEC (AIBILI- Clinical Trials Centre)
Oct 2, 2023
Type-2 Diabetic Patients Trial in Cairo (Reiki Therapy, Qi-gong Therapy)
Recruiting
- Type-2 Diabetic Patients
- Reiki Therapy
- Qi-gong Therapy
-
Cairo, EgyptThe National Institute of Diabetes and Endocrinology's Hospital
Jan 28, 2023
Diabetic Foot, Peripheral Neuropathy With Type 2 Diabetes Trial in Mersin (Routine Medical Treatment, Aerobic Exercise, Aerobic
Not yet recruiting
- Diabetic Foot
- Peripheral Neuropathy With Type 2 Diabetes
- Routine Medical Treatment
- +2 more
-
Mersin, Famagusta, TurkeyEastern Mediterranean University
Aug 8, 2022
Type 2 Diabetes Trial in Beijing (HS-20094 5mg, HS-20094 10mg, HS-20094 15mg)
Recruiting
- Type 2 Diabetes
- HS-20094 5mg
- +3 more
-
Beijing, Beijing, ChinaPeking University First Hospital
Nov 3, 2023
Diabetes Type 2, Malnutrition Trial in Málaga (Fortimel energy, Nutrision Advanced Diason Energy HP)
Recruiting
- Diabetes Type 2
- Malnutrition
- Fortimel energy
- Nutrision Advanced Diason Energy HP
-
Málaga, SpainHospital Regional Universitario de Málaga
Oct 6, 2022
Immunization, HPV Infection, Human Papillomavirus Trial in Galveston (9-valent HPV vaccine, 2 doses alternate timing, 9-valent
Recruiting
- Immunization
- +2 more
- 9-valent HPV vaccine, 2 doses alternate timing
- 9-valent HPV vaccine, 3 doses standard timing
-
Galveston, TexasUniversity of Texas Medical Branch
Jan 30, 2023
SARS-CoV-2 Infection Trial in Mexico (AVX-COVID/12, ChAdOx-1-S[recombinant])
Recruiting
- SARS-CoV-2 Infection
- AVX-COVID/12
- ChAdOx-1-S[recombinant]
-
Mexico City, Cdmx, Mexico
- +13 more
Feb 3, 2023
Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)
Not yet recruiting
- Immunogenicity
- Safety
- Phase II:SWIM816;SARS-Cov-2;
- +3 more
- (no location specified)
Jun 18, 2023
Type 2 Diabetes Trial in Taipei (TMU-LOVE)
Completed
- Type 2 Diabetes
- TMU-LOVE
-
Taipei, TaiwanSchool of Pharmacy, Taipei Medical University
Mar 16, 2022
Rheumatoid Arthritis Trial in United States (procedure, drug, device)
Recruiting
- Rheumatoid Arthritis
- Implant Procedure
- +3 more
-
Birmingham, Alabama
- +33 more
Jan 3, 2023
Electrolyte Disorders in Prediabetics and in Type 2 Diabetes
Not yet recruiting
- Type 2 Diabetes Mellitus and Electrolyte Disorders
- (no location specified)
Apr 2, 2023
Endocrinology, Type 2 Diabetes Trial (Freestyle Libre 2, Therapeutic education)
Not yet recruiting
- Endocrinology
- Type 2 Diabetes
- Freestyle Libre 2
- Therapeutic education
- (no location specified)
Jan 12, 2023
Pancreatic Lipomatosis Trial in Chandigarh (Dapagliflozin 10mg Tab)
Completed
- Pancreatic Lipomatosis
- Dapagliflozin 10mg Tab
-
Chandigarh, IndiaDeptt of Endocrinology
Apr 6, 2023
Pre Diabetes, Obesity, Metabolic Syndrome Trial in Milwaukee (Control, 2-Hour Stand Group, 3-Hour Stand Group)
Not yet recruiting
- Pre Diabetes
- +3 more
- Control
- +2 more
-
Milwaukee, WisconsinMedical College of Wisconsin
Oct 18, 2022
Pre-hypertension, Cardiovascular Diseases Trial in Chicago (Watermelon Flesh Dose 1, Watermelon Flesh Dose 2, Control)
Recruiting
- Pre-hypertension
- Cardiovascular Diseases
- Watermelon Flesh Dose 1
- +2 more
-
Chicago, IllinoisClinical Nutrition Research Center
May 26, 2023
Fatty Liver, Nonalcoholic, Diabetes, Type 2 Trial in Alexandria (Metformin)
Active, not recruiting
- Fatty Liver, Nonalcoholic
- Diabetes Mellitus, Type 2
-
Alexandria, EgyptAlexandria University.
Jan 14, 2022
Mobile Health, Type 2 Diabetes, Patient Activation Trial in Antalya (DiaPaDeSS)
Not yet recruiting
- Mobile Health
- +6 more
- DiaPaDeSS
-
Antalya, Antalya, Turkey, TurkeyAkdeniz University
Jun 14, 2023
Community-based Primary Care Program Effects on Pharmacotherapy
Completed
- Type 2 Diabetes
- Hypertension
- community-based primary care program
- (no location specified)
Jul 30, 2023
Gestational Diabetes in Pregnancy, Type 2 Diabetes Trial in Lexington, Louisville (Fresh Funds for Mom's, Standard Medical care,
Not yet recruiting
- Gestational Diabetes Mellitus in Pregnancy
- Type 2 Diabetes Mellitus
- Fresh Funds for Mom's
- +2 more
-
Lexington, Kentucky
- +1 more
Jul 28, 2023
Human Papillomavirus Infection Trial in Kunming (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus
Active, not recruiting
- Human Papillomavirus Infection
- Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
- GARDASIL® 9
-
Kunming, Yunnan, ChinaYunnan Center for Disease Prevention and Control
Dec 23, 2022